← SynDRA
TYRPHOSTIN 23
SynDRA canonical compound SYN0003279 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | EGFR |
|---|
| Mechanism of action | EGFR inhibitor | tyrosine kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- EGFR INHIBITOR
- tyrosine kinase inhibitor
Drug classes
- Antineoplastic Agents
- Enzyme Inhibitors
Cross-references
Synonyms
- RG 50810
- Tyrphostin A23
- AG-18
- (3,4-Dihydroxybenzylidene)malononitrile
- Tyrphostin AG18
- Tyrphostin RG50810
- 2-(3,4-dihydroxybenzylidene)malononitrile
- UNII-RV0GCD31OJ
- alpha-Cyano-(3,4-dihydroxy)cinnamonitrile
- 2-[(3,4-dihydroxyphenyl)methylidene]propanedinitrile
- Propanedinitrile,2-[(3,4-dihydroxyphenyl)methylene]-
- ag18
- (3,4-Dihydroxyphenyl)methylene propanedinitrile
- RV0GCD31OJ
- C10H6N2O2
- NCGC00016043-03
- (3,4-dihydroxybenzylidene)propanedinitrile
- DSSTox_CID_25215
- BRD-K49657628
- tyrphostin-AG-18
- 3,4-dihydroxybenzylidenemalononitrile
- RefChem:900829
- MFCD00133899
- AG 18 (Tyrphostin 23)
- ((3,4-Dihydroxyphenyl)methylene)-Propanedinitrile
- DTXCID7025215
- CAS-118409-57-7
- SR-01000075506
- Tocris-0493
- BiomolKI_000011
- Lopac-T-7165
- BiomolKI2_000021
- cid_2052
- Lopac0_001160
- Oprea1_072726
- Tyrphostin 23, >=98%
- MLS002153315
- SCHEMBL241922
Look up TYRPHOSTIN 23 in the interactive SynDRA portal →